查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1580871

藥物輸送系統市場：按輸送類型、配方、藥物釋放機制、應用、最終用戶 - 2025-2030 年全球預測

Drug Delivery Systems Market by Delivery Type (Inhalation Drug Delivery, Injection-Based Delivery, Nasal Drug Delivery), Formulation (Gas, Liquid, Semisolid), Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年給藥系統市值為370.4億美元，預計到2024年將達到390.2億美元，複合年成長率為5.70%，到2030年將達到546.1億美元。

藥物傳遞系統的範圍包括用於治療劑的靶向輸送和控制釋放的技術。這些系統透過確保藥物以最佳濃度到達所需的作用部位，對於提高藥物治療的有效性、安全性和患者依從性至關重要。藥物輸送系統以多種形式應用，包括口服、注射、經皮、吸入和植入裝置，並服務醫院、診所和家庭護理的廣泛最終用途。在生物技術和奈米技術進步的推動下，對更精確、更有效率和對患者友好的治療解決方案的持續需求凸顯了對複雜藥物傳輸機制的需求。

主要市場統計
基準年[2023] 370.4億美元
預測年份 [2024] 390.2億美元
預測年份 [2030] 546.1億美元
複合年成長率（%） 5.70%

影響該市場的關鍵成長要素包括慢性病盛行率的增加、對生技藥品和生物相似藥的需求不斷成長以及輸送技術的創新。此外，個人化醫療和生物療法的興起為提高標靶效果和生物有效性的新型遞送系統提供了重大機會。例如，智慧給藥平台和微粒技術等技術創新是高成長的潛在領域。希望利用這些機會的公司應該投資於生物分解性聚合物和奈米載體等尖端系統的研究和開發。然而，市場面臨監管複雜性、開發成本高和生物技術知識有限等挑戰，抑制了創新和採用的速度。

藥物穩定性和患者依從性的限制也是需要解決的障礙。未來的創新應專注於透過加強材料科學和工程的發展以及創建更具適應性和響應性的交付系統來克服這些障礙。探索數位健康技術的協同使用可以進一步完善監測和管理並改善藥物傳輸環境。總體而言，給藥系統市場是一個充滿活力且充滿挑戰的市場，需要對技術和監管導航進行策略性投資，以抓住新機會並促進永續的市場成長。

市場動態：快速發展的給藥系統市場的關鍵市場洞察

供需的動態交互作用正在改變給藥系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界各地慢性病感染疾病流行範圍擴大
    • 政府加大對醫療基礎建設的支持
    • 個人化醫療需求不斷成長
  • 市場限制因素
    • 開發藥物輸送系統的高成本
  • 市場機會
    • 藥物輸送系統製造的技術進步
    • 擴大奈米技術在高效標靶藥物傳輸系統的應用
  • 市場挑戰
    • 監管障礙和漫長的核准流程

波特五力：駕馭給藥系統市場的策略工具

波特的五力框架是了解藥物輸送系統市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物輸送系統市場的外部影響

外部宏觀環境因素在塑造給藥系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解給藥系統市場的競爭狀況

藥物輸送系統市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣給藥系統市場供應商績效評估

FPNV 定位矩陣是評估藥物傳輸系統市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃藥物輸送系統市場的成功之路

藥物輸送系統市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和感染疾病的盛行率正在增加。
      • 加大醫療基礎建設投資、政府支持
      • 個人化醫療需求不斷成長
    • 抑制因素
      • 開發藥物輸送系統的高成本
    • 機會
      • 藥物輸送系統生產的技術進步
      • 擴大奈米技術在高效標靶藥物傳輸系統的應用
    • 任務
      • 監管障礙和漫長的核准流程
  • 市場區隔分析
    • 給藥方法：擴大採用經皮給藥以確保長期、受控的藥物釋放。
    • 應用：糖尿病的全球流行增加了對持續給藥系統的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依輸送類型分類的藥物輸送系統市場

  • 吸入給藥
  • 注射輸送
  • 鼻內給藥
  • 眼科藥物輸送
  • 口服給藥
  • 局部給藥
  • 經經皮給藥

第7章依製劑分類的給藥系統市場

  • 氣體
  • 液體
  • 半固體
  • 固體的

第8章依藥物釋放機制分類的藥物輸送系統市場

  • 控釋
  • 即時釋放
  • 持續釋放
  • 目標發布

第9章給藥系統市場：依應用分類

  • 心血管疾病
  • 中樞神經系統疾病
  • 糖尿病
  • 感染疾病
  • 腫瘤學
  • 呼吸系統疾病

第 10 章 給藥系統市場：依最終使用者分類

  • 診斷中心
  • 家庭護理設置
  • 醫院/診所

第11章 北美和南美給藥系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太藥物傳輸系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的給藥系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Schott Pharma 和 Koru Medical Systems 合作開發創新藥物傳輸以改善患者照護
    • Difgen 透過收購 FDA 註冊設施來提高產量和質量
    • Sharp Corporation Technology 推出新型藥物輸送系統，可提高病患安全並降低給藥風險
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Boston Scientific Corporation
  • Cospheric LLC
  • DelSiTech Ltd.
  • Enable Injections, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Merit Medical Systems, Inc.
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Polysciences Inc.
  • Sanofi SA
  • SHL Medical
  • Societal CDMO by CoreRx, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-CA7E340319CB

The Drug Delivery Systems Market was valued at USD 37.04 billion in 2023, expected to reach USD 39.02 billion in 2024, and is projected to grow at a CAGR of 5.70%, to USD 54.61 billion by 2030.

The scope of drug delivery systems encompasses the technologies used for the targeted delivery and controlled release of therapeutic agents. These systems are vital for enhancing the efficacy, safety, and patient compliance of pharmaceutical treatments by ensuring that drugs reach their intended site of action in optimal concentrations. Drug delivery systems are applied across various modalities including oral, injectable, transdermal, inhalation, and implantable devices, catering to a broad end-use base in hospitals, clinics, and home care settings. The necessity of sophisticated drug delivery mechanisms is underscored by the ongoing demand for more precise, efficient, and patient-friendly treatment solutions, fueled by advancements in biotechnology and nanotechnology.

KEY MARKET STATISTICS
Base Year [2023] USD 37.04 billion
Estimated Year [2024] USD 39.02 billion
Forecast Year [2030] USD 54.61 billion
CAGR (%) 5.70%

Key growth factors influencing this market include increasing prevalence of chronic diseases, growing demand for biologics and biosimilars, and technological innovations in delivery techniques. Additionally, the rise in personalized medicine and biologic therapies presents significant opportunities for novel delivery systems that improve targeted action and bioavailability. For instance, innovations such as smart drug delivery platforms and microparticle technologies are potential areas with high growth prospects. Businesses looking to capitalize on these opportunities should invest in R&D for cutting-edge systems like biodegradable polymers and nanocarriers. However, the market faces challenges from regulatory complexities, high developmental costs, and limitations in biotechnology knowledge, which can impede the rate of innovation and adoption.

Limitations in drug stability and patient adherence also pose hurdles that need addressing. Future innovation should focus on overcoming these barriers by enhancing materials science and engineering developments to create more adaptive and responsive delivery systems. Exploring the synergistic use of digital health technologies can further refine monitoring and management, enhancing the drug delivery landscape. Overall, the drug delivery systems market is both dynamic and challenging, requiring strategic investments in technology and regulatory navigation to seize emerging opportunities and drive sustained market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Systems Market

The Drug Delivery Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic & infectious diseases across the globe
    • Rising investment government support for healthcare infrastructure
    • Upsurge in the demand for personalized medicine
  • Market Restraints
    • High cost associated with development of drug delivery systems
  • Market Opportunities
    • Technological advancements in the production of drug delivery systems
    • Growing adoption of nanotechnology for efficient targeted drug delivery systems
  • Market Challenges
    • Regulatory hurdles and time-consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Systems Market

A detailed market share analysis in the Drug Delivery Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Systems Market

A strategic analysis of the Drug Delivery Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AptarGroup, Inc., AstraZeneca Plc, Boston Scientific Corporation, Cospheric LLC, DelSiTech Ltd., Enable Injections, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., SHL Medical, Societal CDMO by CoreRx, Inc., Terumo Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Delivery Type, market is studied across Inhalation Drug Delivery, Injection-Based Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, and Transdermal Drug Delivery.
  • Based on Formulation, market is studied across Gas, Liquid, Semisolid, and Solid.
  • Based on Drug Release Mechanism, market is studied across Controlled Release, Immediate Release, Sustained Release, and Targeted Release.
  • Based on Application, market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
  • Based on End-User, market is studied across Diagnostic Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic & infectious diseases across the globe
      • 5.1.1.2. Rising investment government support for healthcare infrastructure
      • 5.1.1.3. Upsurge in the demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with development of drug delivery systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the production of drug delivery systems
      • 5.1.3.2. Growing adoption of nanotechnology for efficient targeted drug delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and time-consuming approval processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Delivery Type: Growing adoption transdermal drug delivery to ensure prolonged and controlled drug release
    • 5.2.2. Application: Growing prevalence of diabetes globally push need for continuous drug delivery system
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Systems Market, by Delivery Type

  • 6.1. Introduction
  • 6.2. Inhalation Drug Delivery
  • 6.3. Injection-Based Delivery
  • 6.4. Nasal Drug Delivery
  • 6.5. Ocular Drug Delivery
  • 6.6. Oral Drug Delivery
  • 6.7. Topical Drug Delivery
  • 6.8. Transdermal Drug Delivery

7. Drug Delivery Systems Market, by Formulation

  • 7.1. Introduction
  • 7.2. Gas
  • 7.3. Liquid
  • 7.4. Semisolid
  • 7.5. Solid

8. Drug Delivery Systems Market, by Drug Release Mechanism

  • 8.1. Introduction
  • 8.2. Controlled Release
  • 8.3. Immediate Release
  • 8.4. Sustained Release
  • 8.5. Targeted Release

9. Drug Delivery Systems Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Central Nervous System Disorders
  • 9.4. Diabetes
  • 9.5. Infectious Diseases
  • 9.6. Oncology
  • 9.7. Respiratory Diseases

10. Drug Delivery Systems Market, by End-User

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals & Clinics

11. Americas Drug Delivery Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Drug Delivery Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Drug Delivery Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Schott Pharma and Koru Medical Systems Partner to Innovate Drug Delivery for Improved Patient Care
    • 14.3.2. Difgen Boosts Production and Quality with Acquisition of FDA-Registered Facility
    • 14.3.3. Sharps Technology Launches New Drug Delivery Systems to Enhance Patient Safety and Reduce Administration Risks
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AptarGroup, Inc.
  • 3. AstraZeneca Plc
  • 4. Boston Scientific Corporation
  • 5. Cospheric LLC
  • 6. DelSiTech Ltd.
  • 7. Enable Injections, Inc.
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Insulet Corporation
  • 10. Johnson & Johnson Services, Inc.
  • 11. Lonza Group Ltd.
  • 12. Merck KGaA
  • 13. Merit Medical Systems, Inc.
  • 14. Novartis AG
  • 15. Pacira BioSciences, Inc.
  • 16. Pfizer Inc.
  • 17. Polysciences Inc.
  • 18. Sanofi S.A.
  • 19. SHL Medical
  • 20. Societal CDMO by CoreRx, Inc.
  • 21. Terumo Corporation
  • 22. Thermo Fisher Scientific Inc.
  • 23. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTION-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SEMISOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023